Skip to main content
Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · IEX Real-Time Price · USD
1.350
+0.180 (15.38%)
At close: Jul 26, 2024, 3:58 PM
1.360
+0.010 (0.74%)
After-hours: Jul 26, 2024, 7:56 PM EDT

Virax Biolabs Group Revenue

Virax Biolabs Group had revenue of $76.50K in the half year ending September 30, 2023. This brings the company's revenue in the last twelve months to $79.30K, up 1,276.75% year-over-year. In the fiscal year ending March 31, 2023, Virax Biolabs Group had annual revenue of $8.56K.

Revenue (ttm)
$79.30K
Revenue Growth
+1,276.75%
P/S Ratio
40.80
Revenue / Employee
$7,209
Employees
11
Market Cap
3.24M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20238.56K--
Mar 31, 2022---
Mar 31, 2021123.82K23.94K23.97%
Mar 31, 202099.88K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

VRAX News

More News